Stacy E.F. Melanson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse Detection | 18 | 2024 | 301 | 5.200 |
Why?
|
| Immunoassay | 13 | 2024 | 746 | 3.050 |
Why?
|
| Tandem Mass Spectrometry | 13 | 2024 | 1186 | 2.410 |
Why?
|
| Chromatography, Liquid | 12 | 2024 | 986 | 2.400 |
Why?
|
| Urinalysis | 8 | 2021 | 368 | 2.250 |
Why?
|
| Phlebotomy | 6 | 2017 | 137 | 1.600 |
Why?
|
| Drug Monitoring | 7 | 2021 | 960 | 1.570 |
Why?
|
| Laboratories | 10 | 2021 | 460 | 1.450 |
Why?
|
| Clinical Laboratory Information Systems | 4 | 2017 | 108 | 1.420 |
Why?
|
| Fentanyl | 4 | 2024 | 433 | 1.270 |
Why?
|
| Analgesics, Opioid | 13 | 2024 | 3765 | 1.080 |
Why?
|
| Cannabis | 2 | 2023 | 436 | 1.050 |
Why?
|
| Chemistry, Clinical | 5 | 2024 | 64 | 1.020 |
Why?
|
| Buprenorphine | 4 | 2019 | 654 | 0.940 |
Why?
|
| Saliva | 2 | 2019 | 820 | 0.860 |
Why?
|
| Clinical Laboratory Techniques | 4 | 2024 | 748 | 0.810 |
Why?
|
| Efficiency, Organizational | 4 | 2017 | 696 | 0.790 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 4402 | 0.780 |
Why?
|
| Piracetam | 1 | 2021 | 88 | 0.760 |
Why?
|
| Cannabinoids | 1 | 2023 | 172 | 0.720 |
Why?
|
| Blood Specimen Collection | 4 | 2018 | 238 | 0.700 |
Why?
|
| Workflow | 7 | 2021 | 850 | 0.670 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2014 | 496 | 0.650 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 461 | 0.650 |
Why?
|
| Troponin I | 5 | 2015 | 632 | 0.620 |
Why?
|
| Hallucinogens | 1 | 2021 | 194 | 0.610 |
Why?
|
| Medication Adherence | 4 | 2017 | 2155 | 0.600 |
Why?
|
| Academic Medical Centers | 5 | 2018 | 2751 | 0.550 |
Why?
|
| Patient Compliance | 3 | 2019 | 2685 | 0.530 |
Why?
|
| Clonazepam | 1 | 2016 | 134 | 0.520 |
Why?
|
| Myoglobin | 2 | 2006 | 159 | 0.500 |
Why?
|
| Pain | 5 | 2014 | 5065 | 0.480 |
Why?
|
| Hospital Information Systems | 1 | 2017 | 393 | 0.470 |
Why?
|
| Coma | 1 | 2018 | 482 | 0.470 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1705 | 0.450 |
Why?
|
| Emergency Service, Hospital | 9 | 2024 | 7810 | 0.450 |
Why?
|
| Analgesics | 4 | 2021 | 1064 | 0.450 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2006 | 1704 | 0.440 |
Why?
|
| Electronic Health Records | 5 | 2018 | 4761 | 0.440 |
Why?
|
| Vancomycin | 2 | 2013 | 503 | 0.440 |
Why?
|
| Laboratories, Hospital | 4 | 2017 | 192 | 0.420 |
Why?
|
| Point-of-Care Systems | 5 | 2022 | 1201 | 0.420 |
Why?
|
| Glucuronidase | 1 | 2014 | 202 | 0.420 |
Why?
|
| Limit of Detection | 3 | 2024 | 270 | 0.410 |
Why?
|
| Benzodiazepines | 2 | 2018 | 1130 | 0.400 |
Why?
|
| Creatine Kinase, MB Form | 2 | 2014 | 202 | 0.380 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 1090 | 0.380 |
Why?
|
| False Positive Reactions | 5 | 2018 | 956 | 0.360 |
Why?
|
| Sensitivity and Specificity | 12 | 2023 | 14641 | 0.360 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2010 | 110 | 0.350 |
Why?
|
| Legislation, Drug | 2 | 2023 | 214 | 0.350 |
Why?
|
| Humans | 88 | 2024 | 758381 | 0.350 |
Why?
|
| Patient Identification Systems | 1 | 2010 | 75 | 0.340 |
Why?
|
| Narcotics | 1 | 2012 | 336 | 0.340 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 244 | 0.340 |
Why?
|
| Peptide Fragments | 3 | 2006 | 5098 | 0.330 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 2142 | 0.300 |
Why?
|
| Troponin T | 3 | 2011 | 761 | 0.300 |
Why?
|
| Pain Measurement | 2 | 2018 | 3527 | 0.300 |
Why?
|
| Autoanalysis | 1 | 2007 | 71 | 0.300 |
Why?
|
| Cost Savings | 1 | 2013 | 918 | 0.290 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2009 | 389 | 0.290 |
Why?
|
| Enzyme Multiplied Immunoassay Technique | 1 | 2006 | 7 | 0.290 |
Why?
|
| Medical Errors | 2 | 2018 | 1255 | 0.280 |
Why?
|
| Promethazine | 1 | 2006 | 29 | 0.280 |
Why?
|
| Benchmarking | 1 | 2013 | 1042 | 0.280 |
Why?
|
| Fish Oils | 2 | 2005 | 481 | 0.270 |
Why?
|
| Epilepsy | 1 | 2021 | 3269 | 0.260 |
Why?
|
| Blood Gas Analysis | 1 | 2007 | 377 | 0.260 |
Why?
|
| Boston | 6 | 2024 | 9304 | 0.260 |
Why?
|
| Amphetamine | 1 | 2006 | 224 | 0.250 |
Why?
|
| Troponin | 2 | 2014 | 500 | 0.250 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 3446 | 0.250 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 431 | 0.250 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2006 | 227 | 0.240 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2218 | 0.240 |
Why?
|
| Vaccines | 2 | 2024 | 832 | 0.240 |
Why?
|
| Donor Selection | 1 | 2006 | 227 | 0.240 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2014 | 787 | 0.240 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2006 | 418 | 0.230 |
Why?
|
| Clinical Chemistry Tests | 1 | 2004 | 59 | 0.230 |
Why?
|
| Blood Donors | 1 | 2006 | 343 | 0.230 |
Why?
|
| Health Planning Guidelines | 1 | 2005 | 151 | 0.230 |
Why?
|
| Drug Prescriptions | 3 | 2011 | 1668 | 0.230 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2005 | 120 | 0.220 |
Why?
|
| Peroxidase | 1 | 2006 | 605 | 0.220 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2768 | 0.220 |
Why?
|
| Colorado | 1 | 2023 | 164 | 0.210 |
Why?
|
| Medical History Taking | 1 | 2006 | 772 | 0.210 |
Why?
|
| Running | 1 | 2006 | 483 | 0.200 |
Why?
|
| Education, Medical | 1 | 2013 | 1725 | 0.200 |
Why?
|
| Reproducibility of Results | 7 | 2024 | 20052 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 2239 | 0.190 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 103 | 0.180 |
Why?
|
| Creatinine | 3 | 2022 | 1892 | 0.180 |
Why?
|
| Outpatients | 3 | 2021 | 1591 | 0.180 |
Why?
|
| Pandemics | 4 | 2024 | 8611 | 0.180 |
Why?
|
| Acute Coronary Syndrome | 2 | 2014 | 2180 | 0.170 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2019 | 20 | 0.170 |
Why?
|
| Antibodies, Viral | 4 | 2024 | 3142 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2006 | 1321 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2020 | 1539 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 979 | 0.170 |
Why?
|
| Bicycling | 1 | 2020 | 176 | 0.160 |
Why?
|
| Immunochemistry | 1 | 2018 | 119 | 0.160 |
Why?
|
| Analgesia, Obstetrical | 1 | 2020 | 169 | 0.160 |
Why?
|
| Dyspnea | 1 | 2006 | 1344 | 0.150 |
Why?
|
| Ethanol | 1 | 2024 | 1325 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 1176 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 1529 | 0.150 |
Why?
|
| Mercury | 2 | 2005 | 288 | 0.140 |
Why?
|
| Chest Pain | 1 | 2004 | 1090 | 0.140 |
Why?
|
| Analgesia, Epidural | 1 | 2020 | 330 | 0.140 |
Why?
|
| Myocardial Infarction | 3 | 2015 | 11424 | 0.140 |
Why?
|
| Naloxone | 1 | 2019 | 369 | 0.140 |
Why?
|
| Attitude to Computers | 1 | 2017 | 195 | 0.130 |
Why?
|
| Body Fluids | 1 | 2018 | 319 | 0.130 |
Why?
|
| Quality Control | 1 | 2018 | 825 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2010 | 6548 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2005 | 1373 | 0.120 |
Why?
|
| Automobile Driving | 1 | 2020 | 438 | 0.120 |
Why?
|
| Morphine | 2 | 2014 | 653 | 0.120 |
Why?
|
| Pathology, Clinical | 1 | 2018 | 375 | 0.120 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 814 | 0.120 |
Why?
|
| Myocardium | 1 | 2007 | 4690 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 583 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2024 | 4540 | 0.120 |
Why?
|
| Kidney Function Tests | 2 | 2008 | 677 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2022 | 6347 | 0.110 |
Why?
|
| Female | 19 | 2024 | 390316 | 0.110 |
Why?
|
| Middle Aged | 16 | 2024 | 219560 | 0.110 |
Why?
|
| Refrigeration | 1 | 2013 | 27 | 0.110 |
Why?
|
| Specimen Handling | 3 | 2019 | 707 | 0.110 |
Why?
|
| Porphyrias | 1 | 2003 | 57 | 0.110 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2013 | 38 | 0.110 |
Why?
|
| Morphine Derivatives | 1 | 2013 | 42 | 0.110 |
Why?
|
| Urate Oxidase | 1 | 2013 | 31 | 0.110 |
Why?
|
| Calibration | 1 | 2016 | 814 | 0.110 |
Why?
|
| Documentation | 1 | 2019 | 892 | 0.110 |
Why?
|
| Walking | 1 | 2020 | 1188 | 0.110 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2540 | 0.110 |
Why?
|
| Coronary Disease | 1 | 2007 | 5917 | 0.100 |
Why?
|
| Forensic Toxicology | 1 | 2012 | 5 | 0.100 |
Why?
|
| Tramadol | 1 | 2013 | 60 | 0.100 |
Why?
|
| Urine | 1 | 2014 | 363 | 0.100 |
Why?
|
| United States | 5 | 2023 | 72140 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5649 | 0.100 |
Why?
|
| Oligopeptides | 3 | 2004 | 1185 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2006 | 5070 | 0.100 |
Why?
|
| Time | 1 | 2013 | 543 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2005 | 3388 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1881 | 0.100 |
Why?
|
| Adult | 12 | 2024 | 219916 | 0.100 |
Why?
|
| Time Factors | 6 | 2017 | 39873 | 0.090 |
Why?
|
| Physical Exertion | 2 | 2006 | 662 | 0.090 |
Why?
|
| Male | 20 | 2024 | 358742 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4336 | 0.090 |
Why?
|
| Myeloablative Agonists | 1 | 2010 | 209 | 0.090 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2010 | 64 | 0.090 |
Why?
|
| Creatine Kinase | 3 | 2014 | 686 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2359 | 0.080 |
Why?
|
| Substance P | 2 | 2000 | 333 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1926 | 0.080 |
Why?
|
| Oxycodone | 1 | 2010 | 138 | 0.080 |
Why?
|
| Automation | 1 | 2011 | 581 | 0.080 |
Why?
|
| Cocaine | 1 | 2013 | 958 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2024 | 80170 | 0.080 |
Why?
|
| Reference Values | 3 | 2014 | 4919 | 0.070 |
Why?
|
| Uric Acid | 1 | 2013 | 803 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 2154 | 0.070 |
Why?
|
| Ultrasonography | 2 | 1999 | 5952 | 0.070 |
Why?
|
| Acute Disease | 2 | 2007 | 7225 | 0.070 |
Why?
|
| Teratogens | 1 | 2006 | 117 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 341 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2359 | 0.060 |
Why?
|
| Serum | 1 | 2006 | 210 | 0.060 |
Why?
|
| Aged | 7 | 2024 | 168217 | 0.060 |
Why?
|
| Reference Standards | 2 | 2022 | 1003 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 26182 | 0.060 |
Why?
|
| Cross Reactions | 1 | 2006 | 818 | 0.060 |
Why?
|
| Receptors, Tachykinin | 1 | 2004 | 25 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5331 | 0.060 |
Why?
|
| Data Collection | 2 | 2011 | 3322 | 0.060 |
Why?
|
| Pesticide Residues | 1 | 2005 | 95 | 0.060 |
Why?
|
| Nurses | 1 | 2013 | 2467 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7338 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1588 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 158 | 0.060 |
Why?
|
| Inpatients | 2 | 2014 | 2551 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 397 | 0.060 |
Why?
|
| Receptors, Opioid | 1 | 2004 | 145 | 0.060 |
Why?
|
| Fiber Optic Technology | 1 | 1995 | 289 | 0.060 |
Why?
|
| Societies | 1 | 2024 | 108 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2005 | 519 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3867 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1386 | 0.050 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2005 | 236 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2004 | 523 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 2 | 2023 | 1931 | 0.050 |
Why?
|
| Albumins | 1 | 2005 | 575 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2008 | 15225 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2018 | 5865 | 0.050 |
Why?
|
| Probability | 1 | 2006 | 2467 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2023 | 54136 | 0.050 |
Why?
|
| Hospitals | 2 | 2022 | 3888 | 0.050 |
Why?
|
| ROC Curve | 2 | 2006 | 3563 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 424 | 0.050 |
Why?
|
| Capnography | 1 | 2001 | 91 | 0.050 |
Why?
|
| Apgar Score | 1 | 2020 | 126 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 270 | 0.040 |
Why?
|
| American Heart Association | 1 | 2005 | 1039 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2010 | 10112 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1686 | 0.040 |
Why?
|
| Alleles | 1 | 2010 | 6895 | 0.040 |
Why?
|
| Commerce | 1 | 2005 | 603 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 617 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2215 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4317 | 0.040 |
Why?
|
| Injections, Spinal | 2 | 2013 | 317 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 1890 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 457 | 0.040 |
Why?
|
| Workload | 1 | 2004 | 847 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1533 | 0.040 |
Why?
|
| Indoles | 2 | 2004 | 1828 | 0.040 |
Why?
|
| Polymers | 1 | 1995 | 1615 | 0.040 |
Why?
|
| Blood Banks | 1 | 2018 | 108 | 0.040 |
Why?
|
| Vitamin D | 1 | 2012 | 3283 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39060 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 463 | 0.040 |
Why?
|
| Maternal Age | 1 | 2020 | 807 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2690 | 0.040 |
Why?
|
| Ischemia | 1 | 2005 | 1863 | 0.030 |
Why?
|
| Emergency Medical Technicians | 1 | 1997 | 119 | 0.030 |
Why?
|
| Genotype | 1 | 2010 | 12945 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 12951 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3734 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2020 | 933 | 0.030 |
Why?
|
| Risk | 1 | 2006 | 9599 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 2747 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2008 | 5460 | 0.030 |
Why?
|
| Logistic Models | 2 | 2006 | 13276 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2889 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2009 | 9266 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2007 | 3732 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7403 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2001 | 985 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1174 | 0.030 |
Why?
|
| History, 18th Century | 1 | 2003 | 207 | 0.030 |
Why?
|
| Temperature | 1 | 2019 | 2219 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2019 | 1888 | 0.020 |
Why?
|
| HIV | 1 | 1999 | 1581 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 13959 | 0.020 |
Why?
|
| Self Report | 1 | 2023 | 3712 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7377 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 437 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 58681 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2001 | 1494 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 2004 | 367 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2003 | 720 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3356 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1999 | 2836 | 0.020 |
Why?
|
| Seafood | 1 | 2003 | 390 | 0.020 |
Why?
|
| Fishes | 1 | 2003 | 601 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3156 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9160 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13245 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 1999 | 1195 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1263 | 0.020 |
Why?
|
| Palliative Care | 1 | 2024 | 3570 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 1673 | 0.020 |
Why?
|
| Echocardiography | 1 | 2001 | 4962 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2012 | 1159 | 0.020 |
Why?
|
| Pennsylvania | 2 | 1999 | 614 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2004 | 8144 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1997 | 2108 | 0.020 |
Why?
|
| Artifacts | 1 | 2014 | 1897 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 1000 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2003 | 2772 | 0.020 |
Why?
|
| Curriculum | 1 | 2018 | 3717 | 0.020 |
Why?
|
| Prognosis | 1 | 2005 | 29558 | 0.020 |
Why?
|
| Diet | 1 | 2022 | 8003 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1997 | 6363 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 940 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15646 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20500 | 0.010 |
Why?
|
| Receptors, Opioid, mu | 1 | 2004 | 166 | 0.010 |
Why?
|
| Formaldehyde | 1 | 2004 | 358 | 0.010 |
Why?
|
| Exercise | 1 | 1999 | 5788 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15396 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10653 | 0.010 |
Why?
|
| Rats | 3 | 2004 | 23681 | 0.010 |
Why?
|
| Isoindoles | 1 | 2000 | 35 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5861 | 0.010 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2000 | 132 | 0.010 |
Why?
|
| Pain Threshold | 1 | 2004 | 603 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 58808 | 0.010 |
Why?
|
| Methylhistidines | 1 | 1999 | 35 | 0.010 |
Why?
|
| Light | 1 | 1995 | 1345 | 0.010 |
Why?
|
| Patients' Rooms | 1 | 1999 | 61 | 0.010 |
Why?
|
| Catheterization | 1 | 2004 | 1426 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29742 | 0.010 |
Why?
|
| Naltrexone | 1 | 2000 | 317 | 0.010 |
Why?
|
| Reaction Time | 1 | 2004 | 2075 | 0.010 |
Why?
|
| Utilization Review | 1 | 1999 | 382 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 1867 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2850 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 3069 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1999 | 1593 | 0.010 |
Why?
|
| Drug Design | 1 | 2000 | 1049 | 0.010 |
Why?
|
| Neoplasms | 1 | 2024 | 22030 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3425 | 0.010 |
Why?
|
| Animals | 4 | 2004 | 167777 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 73806 | 0.010 |
Why?
|
| Abdomen | 1 | 1999 | 1129 | 0.010 |
Why?
|
| HIV Infections | 1 | 1999 | 17275 | 0.010 |
Why?
|
| Virus Replication | 1 | 1999 | 2430 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1999 | 2490 | 0.010 |
Why?
|
| Neutrophils | 1 | 1999 | 3765 | 0.000 |
Why?
|
| Emergency Medical Services | 1 | 1997 | 1915 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1997 | 12262 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1997 | 4775 | 0.000 |
Why?
|